Some investors are expressing caution about certain stocks, including Moderna, until their next growth engine is clear. Similar reservations have been expressed about other companies, such as Teladoc and Regencell Bioscience. The reasons for this caution are not specified, but it appears that some investors are approaching these stocks with skepticism.